deflazacort
deflazacort is listed in the FDA National Drug Code directory with 15 NDC codes, marketed under brand names including EMFLAZA, DEFLAZACORT, Deflazacort. Available dosage forms: tablet, suspension.
Drug details
- Generic Name
- deflazacort
- Brand Names
- EMFLAZA, DEFLAZACORT, Deflazacort, PYQUVI
- Application Number
- NDA208684
- Sponsor
- PTC Therapeutics, Inc.
- NDC Codes
- 15
- Dosage Forms
- TABLET, SUSPENSION
- Routes
- ORAL
- Active Ingredients
- DEFLAZACORT
Indications and Usage
1 INDICATIONS AND USAGE JAYTHARI is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older. JAYTHARI is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older ( 1 )